Medical diagnostics company Omega Diagnostics (ODX:AIM) said the lead partner in the UK Rapid Test Consortium had reached design freeze for the development of its antibody test strip. The shares gave up 3.5% to 47.5p. The Rapid Test Consortium described the achievement as a ‘major milestone’ and means that the test meets the required performance characteristics and production ...

UK stocks eked out relatively modest gains in early trading on Monday as investors weighed signs of economic recovery with a potential resurgence in coronavirus cases. At 0825, the benchmark FTSE 100 index was up 13.71 points, or 0.2%, at 6,173.01. Mining company Rio Tinto (RIO) shed 0.9% to £44.95, even as it reached an agreement with the government of Mongolia on a new source of domestic ...

In today’s trading update, medical diagnostics company Omega Diagnostics (ODX:AIM) said it expected to report earnings for the year ended 31 March 2020 above market expectations, but this was overshadowed by impairments to its Allergy assets and lower revenues in its Food tolerance business. After surging more than 400% in the last three months, the shares sank 17% to 51p. Omega has ...

UK markets were dragged lower in early trade on Tuesday by worries of investor over-exuberance after another surge for Wall Street overnight. Monday’s rally in US stocks pushed the S&P 500 back into the green for the year as easing lockdowns bolstered optimism on an economic rebound. The benchmark closed at a 15-week high, bringing its rally from the March low to almost 45%, while the ...

UK biotechnology shares have provided some of the best returns in the market over the last six months, driven by a plethora of regulatory news about new products aimed at tackling coronavirus. Shareholders are rightly asking whether the strong share price performances have gone too far in relation to the fundamentals, or maybe in some cases have further to run. We will now talk through the ...

Shares in medical diagnostics company Omega (ODX:AIM) traded 46% higher to 55.5p after the company announced its antibody test for coronavirus has achieved a CE-Mark. This follows-on from a validation from the Liverpool School of Tropical Medicine and St George’s, University of London while ongoing validations are being performed by Public Health England, NHS Scotland and the Republic of ...

UK were firmer at the open on Monday, taking their cue from positive grey market trading on Wall Street and strong Asian gains, after the Bank of Japan expanded its monetary stimulus again. The benchmark FTSE 100 rallied a fraction off 100 point, or 1.7%, to 5,851.95, while the mid cap FTSE 250 charged 2% higher at 15,996.93. Asia markets have got off to a positive start as a raft of ...

Shares in California-based biopharmaceutical firm Gilead Sciences jumped 15% in after-hours trading on 16 April after an industry healthcare magazine reported rapid recoveries in fever and respiratory systems in coronavirus patients given remdesivir in a study being conducted at the University of Chicago Medicine. The news from the leaked report lifted stock markets around the world as ...

UK stock markets lost their modest early gains on Monday as investors continued to mull the damage the coronavirus pandemic is having on the global economy and company earnings. While the benchmark FTSE 100 nudged 0.5% higher in early deals, that positive momentum proved short-lived, with the UK's leading index falling 0.9% into the red at 5,737.31. The more domestic facing FTSE 250 saw a ...

Three of the best performing shares over the last three months are healthcare companies. All of them are at the leading edge, developing testing kits, therapies and vaccines to combat the coronavirus pandemic. Realistically, developing a vaccine will likely take at least 12 months, and so the immediate priority has been to test as many people as possible alongside isolating those with the ...

UK markets make further gains in early trade on Tuesday as investors rally around more declines for the pound and the impact on large overseas earnings for many of the FTSE 100 companies. That comes as energy regulator Ofgem announces a probe into the recent power blackout and National Grid’s (NG.) part in it. Sterling fell 0.4% against the dollar, taking cable (the nickname given to the ...

London’s FTSE 100 trades flat at 7,658.3 points on Monday, the blue chip benchmark’s progress hindered by ongoing tensions over trade between the US and China and some chatter on Brexit. Office space provider IWG (IWG) slumps 23.3% to 230.1p after terminating talks with a trio of companies that had been pursuing a takeover deal for the company and reporting a drop in first half ...

Hayward Tyler (HAYT:AIM) is a gainer in a falling market today as fund manager Richard Sneller lifted a personal stake in the small cap engineer to 6.5%. Hayward's gearing towards the US, China and India, where it sells its industrial pumps, may have played a part in emerging markets specialist Sneller's decision to invest, Shares understands. Sneller has good knowledge of Hayward's ...

Amec better than feared The market likes interims (9 Aug) from oil services firm Amec Foster Wheeler (AMFW). The shares are nearly 10% higher at 510p as results come in slightly better than forecast and 2016 guidance is maintained in the face of challenging markets. The Anglo-American group waved goodbye to chief executive Samir Brikho in January, around 12 months after he created it through a ...

London stock markets open in a cautionary mood in early trade on Tuesday as investors continue to react to yesterday's PMI figures for July, the UK's first real post-Brexit confidence indicator, which showed manufacturing declining at its fastest pace in three years. Today's macroeconomics come in the form of the Markit Construction PMI, while the Eurozone releases PPI data and later US personal ...

The onset of spring means months of itchy eyes and sneezing for many people. The number suffering from allergies, such as hay fever caused by grass and tree pollen, is set to reach one in four of the population, according to eye health specialist Bausch & Lomb. Investors can play the allergy treatment trend via several stocks. More than 150 million people in Europe have at least one ...

London’s blue chip index is trading 21.00 points lower early on Monday at 6,354 on negative updates from commodity and emerging market-focused members of the FTSE 100. FTSE 100 miner BHP Billiton (BLT) falls 3.9% to 776.3p after Brazilian government authorities said they would start legal proceedings against the miner and joint venture partner Vale following a devastating tailings dam breach ...

The ability of micro cap stocks to deliver super-sized returns in super quick time is exemplified by Catalyst Media (CMX:AIM). The £12.3 million cap’s main asset is a 20.5% stake in provider of broadcasting services to bookies Satellite Information Services (SIS) and it is up 63.9% in the space of a week to 50p after SIS secured (23 Sep) a new five year deal with Racecourse Media commencing ...

A sell-off due to delays to a mobile HIV diagnostic’s trials is a buying opportunity at Omega Diagnostics’ (ODX:AIM). Shares in Omega, which specialises in making food intolerance, allergy and infectious disease diagnostics, collapsed 22.8% on news that Visitect CD4 will have to undergo further development due to stability issues. Data collected by the device during initial tests ...

European stock markets continue to slide as the Greece debt saga drags on, with London shares mirroring the performances in financial performance in France and Germany. The FTSE 100 slips 0.3% to 6,516, while France CAC 40 and Germany's Xetra Dax decline by 0.4% and 0.25% respectively. Falling crude prices add to the downward pressure on share prices, with oil services firm Wood Group (WG.) among ...